Portfolio Modeling and Forecasting of Single-Use Rare Disease Treatments
Biopharmaceutical companies are increasingly exploring cutting-edge novel gene therapies (GTs) in an effort to cure rare diseases. This capstone develops and tests a practical forecasting framework for sharing capacity across Roche’s evolving GT portfolio and driving strategic global supply chain ne...
| Main Authors: | , |
|---|---|
| Format: | Other |
| Language: | en_US |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/1721.1/130983 |